Contributor

Julie Grisham, MS

Freelance Science Writer

Recent Blog Posts

Pictured: Charles Sawyers
In the Lab
Research Suggests a New Approach for Overcoming Resistance to a Targeted Therapy for Prostate Cancer
Tuesday, April 30, 2013

Research suggests that a new drug could be effective in patients with prostate cancer who develop resistance to the targeted therapy enzalutamide.

Cancer Biology; Cancer Care; Drug Discovery; Targeted Therapy; Prostate Cancer; Research
Pictured: Gary Schwartz & Mark Dickson
In the Clinic
Studies Show Promise for Treatment Advances in Several Types of Sarcoma
Monday, April 22, 2013

Two clinical trials of targeted therapies led by Memorial Sloan-Kettering investigators show promising results against different types of sarcoma.

Cancer Care; Clinical Trials; Bone Cancer; Targeted Therapy; Treatment; Soft Tissue Sarcoma; Research
Pictured: Megan Harlan Fleischut & Kenneth Offit
Q&A
Genetic Counseling and Genetic Screening for Cancer
Monday, April 15, 2013

Genetic counselor Megan Harlan Fleischut discusses hereditary cancers and the services offered by Memorial Sloan-Kettering’s clinical genetics experts.

Cancer Care; Genetic Testing; Screening
Pictured: Virtual Groups
Event
Virtual Groups Provide Patients with Online Cancer Support and Education
Friday, April 12, 2013

Memorial Sloan-Kettering’s Virtual Groups program offers patients private, online support and education sessions to participate in from home or work.

Cancer Care; Virtual Groups; Counseling & Support
Pictured: José Baselga
Finding
Studies Report on Latest Advances in Targeted Therapy for Breast Cancer
Monday, April 8, 2013

Memorial Sloan-Kettering’s Physician-in-Chief, José Baselga, explains the findings from three studies on new targeted therapies for breast cancer.

Cancer Care; Clinical Trials; Targeted Therapy; Breast Cancer; Research
Pictured: Kenneth Offit
Finding
New Findings May Lead to Better Predictions of Breast Cancer Risk in Women with Inherited Mutations
Thursday, March 28, 2013

A study identifies genetic variations that alter the risk of breast cancer in women who have a certain gene mutation.

Cancer Care; Cancer Genetics; Breast Cancer; Screening; Research
Pictured: ESK1 Monoclonal Antibody
In the Lab
New Molecule Targets Proteins Inside Cancer Cells
Wednesday, March 13, 2013

Scientists from Memorial Sloan-Kettering have collaborated on the discovery of a unique monoclonal antibody, called ESK1, that appears to be effective at targeting and destroying several types of cancer cells.

Targeted Therapy; Molecular Pharmacology; Leukemias; Research
Pictured: Massage Therapy
In the Clinic
Managing Chemotherapy-Induced Peripheral Neuropathy after Cancer Treatment
Monday, March 4, 2013

Peripheral neuropathy — a nerve disorder that can cause weakness, numbness, tingling, and pain — is a common chemotherapy side effect. Treatments are available to help improve your quality of life.

Cancer Care; Integrative Medicine; Treatment; Survivorship
Pictured: Major Trends in Modern Cancer Research Seminar
Video
Scientists Discuss Major Trends in Modern Cancer Research
Friday, March 1, 2013

At the seventh annual seminar for high school students and teachers, investigators discuss how cutting-edge biomedical research may ultimately contribute to better treatments for cancer patients.

Cancer Biology; Pathology; Targeted Therapy; Immunology; Education & Training; Research
Pictured: Prasad Adusumilli
In the Lab
Study Reveals Immune Response as Potential Biomarker to Predict Recurrence of Lung Cancer
Thursday, January 3, 2013

A team from Memorial Sloan-Kettering has found that the makeup of immune cells in a lung tumor and in tissue surrounding a tumor can predict whether the cancer will recur after surgery.

Immunotherapy; Immunology; Lung Cancer; Research
Pictured: Tim Ahles
Q&A
Behavioral Psychologist Tim Ahles Discusses Cognitive Changes Associated with Cancer Treatment
Thursday, December 27, 2012

Problems with cognitive function can significantly impact a person’s quality of life after cancer treatment. New research is focused on the link between cancer treatment and cognitive changes.

Cancer Care; Cognitive Testing; Treatment
Pictured: Michel Sadelain
In the Lab
New Technique Could Make Cell-Based Immune Therapies for Cancer Safer and More Effective
Tuesday, December 18, 2012

Memorial Sloan-Kettering researchers have reported a new method that could allow the development of more-specific, cell-based therapies for cancer.

Cell Therapy; Immunotherapy; Immunology; Research
In the News
The New York Times Commends Memorial Sloan-Kettering’s Stance on a Costly Cancer Drug
Friday, November 16, 2012

Memorial Sloan-Kettering has been praised for taking a stand on the price for a new cancer drug that costs more than twice as much as another, similar drug.

Cancer Care; Treatment
Pictured: Ping Chi
Q&A
At Work: Physician-Scientist Ping Chi
Friday, November 2, 2012

Dr. Chi, a physician-scientist and member of the Human Oncology and Pathogenesis Program, studies genetic and epigenetic changes that cause cancer.

Cancer Care; Cancer Genetics; Targeted Therapy; Melanoma; Soft Tissue Sarcoma; Research
Pictured: Structure of Synthesized Erythropoietin
In the Lab
Memorial Sloan-Kettering Investigators Synthesize Vital Biological Molecule Erythropoietin for the First Time
Monday, October 8, 2012

Researchers have produced a fully synthetic, functional version of erythropoietin, the hormone that controls production of red blood cells.

Chemistry; Molecular Pharmacology; Research